These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Antiplatelet therapy and the risk of intracranial hemorrhage after intravenous tissue plasminogen activator therapy for acute ischemic stroke. Hallevi H; Grotta JC Arch Neurol; 2008 May; 65(5):575-6. PubMed ID: 18474730 [No Abstract] [Full Text] [Related]
9. [Fatal massive hemoptysis during thrombolysis of acute ischemic stroke]. de la Torre-Laviana FJ; Redondo L; Antunez-Infante A; Alvarez-Marquez E Rev Neurol; 2006 Oct 16-31; 43(8):510-1. PubMed ID: 17033985 [No Abstract] [Full Text] [Related]
10. Hemorrhagic transformation after acute ischemic stroke thrombolysis treatment: navigating the landscape of hemostasis genetic risk factors. Bagoly Z J Thromb Haemost; 2024 Apr; 22(4):919-921. PubMed ID: 38521577 [No Abstract] [Full Text] [Related]
11. Hemorrhagic conversion after alteplase administration in a patient with vasculitis and acute ischemic stroke. Gilbert BW; Dhakal L; Lacy A; Huffman JB Am J Health Syst Pharm; 2019 Feb; 76(4):211-213. PubMed ID: 30689698 [TBL] [Abstract][Full Text] [Related]
12. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues. Liang BA; Lew R; Zivin JA Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160 [TBL] [Abstract][Full Text] [Related]
13. Local intra-arterial thrombolysis with urokinase for acute ischemic stroke before and after the approval of intravenous tissue plasminogen activator treatment in Taiwan. Yang FC; Lin CC; Hsueh CJ; Lee JT; Hsu CH; Lee KW; Peng GS Ann Vasc Surg; 2010 Nov; 24(8):1117-24. PubMed ID: 21035704 [TBL] [Abstract][Full Text] [Related]
14. Subtherapeutic warfarin is not associated with increased hemorrhage rates in ischemic strokes treated with tissue plasminogen activator. Vergouwen MD; Casaubon LK; Swartz RH; Fang J; Stamplecoski M; Kapral MK; Silver FL; Stroke; 2011 Apr; 42(4):1041-5. PubMed ID: 21350204 [TBL] [Abstract][Full Text] [Related]
15. The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature. Edwards NJ; Kamel H; Josephson SA Stroke; 2012 Feb; 43(2):412-6. PubMed ID: 22156701 [TBL] [Abstract][Full Text] [Related]
16. Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results From a Multicenter Study. Prats-Sánchez L; Camps-Renom P; Sotoca-Fernández J; Delgado-Mederos R; Martínez-Domeño A; Marín R; Almendrote M; Dorado L; Gomis M; Codas J; Llull L; Gómez González A; Roquer J; Purroy F; Gómez-Choco M; Cánovas D; Cocho D; Garces M; Abilleira S; Martí-Fàbregas J; Stroke; 2016 Aug; 47(8):2003-9. PubMed ID: 27406103 [TBL] [Abstract][Full Text] [Related]
17. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials. Martí-Fàbregas J; Bravo Y; Cocho D; Martí-Vilalta JL; Díaz-Manera J; San Román L; Puig M; Blanco M; Castellanos M; Millán M; Roquer J; Obach V; Maestre J Cerebrovasc Dis; 2007; 23(2-3):85-90. PubMed ID: 17114877 [TBL] [Abstract][Full Text] [Related]
18. Orolingual angioedema with alteplase administration for treatment of acute ischemic stroke. Gorski EM; Schmidt MJ J Emerg Med; 2013 Jul; 45(1):e25-6. PubMed ID: 23664196 [No Abstract] [Full Text] [Related]
19. Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke. Kano T; Katayama Y; Tejima E; Lo EH Brain Res; 2000 Jan; 854(1-2):245-8. PubMed ID: 10784130 [TBL] [Abstract][Full Text] [Related]